183 related articles for article (PubMed ID: 32401349)
1. CCR9 and CCL25: A review of their roles in tumor promotion.
Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
[TBL] [Abstract][Full Text] [Related]
2. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
[TBL] [Abstract][Full Text] [Related]
3. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
[TBL] [Abstract][Full Text] [Related]
4. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
[TBL] [Abstract][Full Text] [Related]
5. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S
World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750
[TBL] [Abstract][Full Text] [Related]
6. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
7. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
[TBL] [Abstract][Full Text] [Related]
8. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
[TBL] [Abstract][Full Text] [Related]
9. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
Atanes P; Lee V; Huang GC; Persaud SJ
Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
[TBL] [Abstract][Full Text] [Related]
10. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
11. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
12. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
[TBL] [Abstract][Full Text] [Related]
15. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.
Uehara S; Song K; Farber JM; Love PE
J Immunol; 2002 Jan; 168(1):134-42. PubMed ID: 11751956
[TBL] [Abstract][Full Text] [Related]
17. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
[TBL] [Abstract][Full Text] [Related]
18. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
[TBL] [Abstract][Full Text] [Related]
19. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
[No Abstract] [Full Text] [Related]
20. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma
Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L
PeerJ; 2022; 10():e13844. PubMed ID: 36003306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
